Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients

Purpose: To determine the effectiveness of adjuvant dendritic cell (DC) vaccination to induce tumor-specific immunological responses in stage III melanoma patients. Experimental design: Retrospective analysis of stage III melanoma patients, vaccinated with autologous monocyte-derived DC loaded with...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncoimmunology
Glavni autori: Boudewijns, Steve, Bol, Kalijn F., Schreibelt, Gerty, Westdorp, Harm, Textor, Johannes C., van Rossum, Michelle M., Scharenborg, Nicole M., de Boer, Annemiek J., van de Rakt, Mandy W. M. M., Pots, Jeanne M., van Oorschot, Tom G. M., Duiveman-de Boer, Tjitske, Olde Nordkamp, Michel A., van Meeteren, Wilmy S. E. C., van der Graaf, Winette T. A., Bonenkamp, Johannes J., de Wilt, Johannes H. W., Aarntzen, Erik H. J. G., Punt, Cornelis J. A., Gerritsen, Winald R., Figdor, Carl G., de Vries, I. Jolanda M.
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2016
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006921/
https://ncbi.nlm.nih.gov/pubmed/27622047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1191732
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items